Results 101 to 110 of about 12,222 (228)

Long-term outcomes after percutaneous withdrawal of HeartWare left ventricular assist device (HVAD) support: A 10-year update

JHLT Open
Ten years have passed since we reported percutaneous decommissioning of an implantable left ventricular assist device (LVAD) using 2 Amplatzer vascular plugs in a 17-year-old male who was bridged to recovery after 22 months of LVAD support.
Chokanan Thaitirarot, Leonard M. Shapiro, Clive Lewis, Jayan Parameshwar, Steven S.L. Tsui, Stephen J. Pettit   +5 more
doaj   +1 more source

Left ventricular assist device-associated endocarditis involving multiple clones of Staphylococcus aureus with distinct antimicrobial susceptibility patterns

International Journal of Infectious Diseases, 2019
The case of a patient with left ventricular assist device (LVAD)-associated endocarditis involving multiple clones of Staphylococcus aureus is presented.
Sohei Harada, Kotaro Aoki, Koh Okamoto, Osamu Kinoshita, Kan Nawata, Yoshikazu Ishii, Kazuhiro Tateda, Masakazu Sasaki, Tomoo Saga, Yohei Doi, Hiroshi Yotsuyanagi, Kyoji Moriya, Minoru Ono   +12 more
doaj   +1 more source

Left ventricular non-compaction cardiomyopathy and left ventricular assist device: a word of caution

, 2016
BACKGROUND: In patients with left ventricular non-compaction (LVNC), implantation of a left ventricular assist device (LVAD) may be performed as a bridge to transplantation.
Risteski, Petar, Kornberger, Angela, Stock, Ulrich Alfred, Beiras Fernández, Andrés   +3 more
core   +1 more source

Cold Atmospheric Plasma Therapy: An Innovative Approach to Treating Driveline Infections in Left Ventricular Assist Device Recipients

Artificial Organs, Volume 50, Issue 6, Page 877-885, June 2026.
Cold atmospheric plasma therapy is an innovative approach to treating driveline infections in left ventricular assist device (LVAD) patients. It provides a safe, contact‐free, and quick treatment option for driveline infections with significant improvement in LVAD patient outcomes and quality of life.
Hebe Al Asadi, Martina Socha, Christiane Marko, Delphine Vanilla Cioffi, Roxana Moayedifar, Julia Riebandt, Daniel Zimpfer, Thomas Schlöglhofer   +7 more
wiley   +1 more source

Modification of a Ventricular Assistance Device for a Hemiplegic Left Ventricular Assist Device Patient [PDF]

, 2019
Neurologic events occur in up to 18% of patients with continuous-flow left ventricular assist devices (LVAD) and is associated with significant morbidity and mortality.
Muslem, Rahat, Rahatullah Muslem, Caliskan, K.C. (Kadir), Bogers, Ad; id_orcid, Hans van Rhijn, Manintveld, O.C. (Olivier), van Rhijn, JHC, Heiden, C. (Colin) van der, van Rhijn, H., Olivier C. Manintveld, Kadir Caliskan, Yalçin, Yunus, Caliskan, Kadir; id_orcid, van der Heiden, C. (Cees), van Rhijn, H. (Hans), Yalcin, Y.C. (Yunus C.), Yunus C. Yalcin, Manintveld, Olivier, Muslem, R. (Rahatullah), Cees van der Heiden, Bogers, A.J.J.C. (Ad), Yalcin, Y.C., Ad J. J. C. Bogers, van der Heiden, CW   +23 more
core   +1 more source

A Blinking Left Ventricular Assist Device

, 2021
A 61-year-old male with history of coronary artery disease and end stage ischemic cardiomyopathy underwent a successful implantation of a HeartMate 3 device with an uneventful recovery.
Guglin, Maya, Rao, Roopa
core   +1 more source

Higher sensitivity to ouabain‐induced toxicity in human induced pluripotent stem cell‐derived cardiomyocytes than human adult heart tissue despite similar Na+/K+‐ATPase pump current amplitudes

British Journal of Pharmacology, Volume 183, Issue 11, Page 3093-3110, June 2026.
Abstract Background and Purpose Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM) have gained interest as a pharmacological model but their immaturity leads to uncertainty regarding translation. We studied the key player in maintaining ionic homeostasis, the Na+/K+‐ATPase (NKA), in hiPSC‐CM.
Djemail Ismaili, Paavo Virtanen, Junsoo Im, Paul Brunnbauer, Umber Saleem, Muhammed Ikbal Sönmez, Carl Schulz, Margaret Nandudu, Joris Winters, Cristina E. Molina, Johannes Petersen, Monika Stoll, Ulrich Schotten, Arne Hansen, Thomas Eschenhagen, Jussi T. Koivumäki, Torsten Christ   +16 more
wiley   +1 more source

Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation

, 2017
We describe the case of a patient implanted with a DeBakey left ventricular assist device (LVAD) as bridge to transplant who survived 7 h of ventricular fibrillation.
Turina, Marko I., Salzberg, Sacha P., Lachat, Mario L., Zünd, Gregor   +3 more
core  

Nocturnal Hypoxemic Burden Predicts Mortality in Patients Awaiting Heart Transplantation

Journal of Sleep Research, Volume 35, Issue 3, June 2026.
Trial design and results on hypoxemic burden in the context of heart transplantation. ABSTRACT Risk stratification for patients with end‐stage heart failure (HF) awaiting heart transplantation (HTX) is crucial. Sleep‐disordered breathing (SDB) is a prevalent comorbidity, yet the impact of its resultant hypoxemic burden remains unclear in this ...
Max Potratz, Tatevik Manukyan, René Schramm, Angelika Costard‐Jäckle, Uwe Fuchs, Michiel Morshuis, Sabina P. W. Guenther, Sebastian V. Rojas, Volker Rudolph, Jan F. Gummert, Henrik Fox   +10 more
wiley   +1 more source

Long‐Term Outcomes of Radiofrequency Atrioventricular Node Ablation in a Real‐World Population

Pacing and Clinical Electrophysiology, Volume 49, Issue 6, Page 698-706, June 2026.
ABSTRACT Background While interventional strategies have expanded the options for long term rhythm restoration, rate control continues to play a pivotal role in the treatment of atrial arrhythmias; however, pharmacologic strategies alone often fail in achieving effective rate control.
Vanessa Sciacca, Nora‐Kristin Brandt, Thomas Fink, Denise Guckel, Maximilian Mörsdorf, Yuri Bocchini, Martin Braun, Moneeb Khalaph, Karen Harutyunyan, Nadica Trajkovska, Philipp Lucas, Thomas Eitz, Maxim Didenko, Philipp Sommer, Christian Sohns   +14 more
wiley   +1 more source